Why Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies In Anaphylm Application – And What's Next

Aquestive Therapeutics recently reported that the FDA has identified unspecified deficiencies in its New Drug Application for ...